Bridgewater, NJ, United States of America

Darshan Parikh

USPTO Granted Patents = 13 (Patent Applications = 2)

EPO Patents = 1 (Patent Applications = 2)

Average Co-Inventor Count = 3.4

ph-index = 6

Forward Citations = 57(Granted Patents)

Company Filing History:

Signal Pharmaceuticals, Inc.

Servier Pharmaceuticals LLC

patents

where one patent can have more than one assignee

Years Active: 2016-2023

Loading Chart...

13 patents (USPTO):Sort by Forward CitationsExplore Patents

1. RE49647 - Formulations of (S)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione (2023-09-11),

2. 11389454 - Tablet compositions (2022-07-19),

3. D858741 - Pharmaceutical tablet (2019-09-03),

4. D835258 - Pharmaceutical tablet (2018-12-04),

5. D835257 - Pharmaceutical tablet (2018-12-04),

6. 10080801 - Formulations of (S)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione (2018-09-25),

7. 10052322 - Pharmaceutical formulations, processes, solid forms and methods of use relating to 1-ethyl-7-(2-methyl-6-(1H-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b]pyrazin-2(1H)-one (2018-08-21),

8. D813372 - Pharmaceutical tablet (2018-03-20),

9. D787043 - Pharmaceutical tablet (2017-05-16),

10. D787042 - Pharmaceutical tablet (2017-05-16),

11. 9468605 - Formulations of (+)-2-[1-(3-ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione (2016-10-18),

12. 9364475 - Tablet formulation of a phosphatidylinositol 3-kinase inhibitor (2016-06-14),

13. 9359364 - Pharmaceutical formulations, processes, solid forms and methods of use relating to 1-ethyl-7-(2-methyl-6-(1H-1,2,4-triazol-3-yl)pyridin-3-yl)-3,4-dihydropyrazino[2,3-b] pyrazin-2(1H)-one (2016-06-07),

Title: The Innovative Contributions of Darshan Parikh

Introduction

Darshan Parikh is a notable inventor based in Bridgewater, NJ (US), recognized for his significant contributions to the pharmaceutical field. With a total of 13 patents to his name, he has made strides in developing innovative formulations and compositions aimed at treating various medical conditions.

Latest Patents

Among his latest patents, Parikh has developed formulations of (S)-3-(4-((4-(morpholinomethyl)benzyl)oxy)-1-oxoisoindolin-2-yl)piperidine-2,6-dione. These patents include pharmaceutical compositions and single unit dosage forms of this compound, which are designed to treat, manage, or prevent disorders such as cancer, inflammatory diseases, and immune-related disorders. Additionally, he has created tablet compositions comprising 2-methyl-1-[(4-[6-(trifluoromethyl)pyridin-2-yl]-6-{[2-(trifluoromethyl)pyridin-4-yl]amino}-1,3,5-triazin-2-yl)amino]propan-2-ol or a pharmaceutically acceptable salt thereof.

Career Highlights

Darshan Parikh has worked with prominent companies in the pharmaceutical industry, including Celgene Corporation and Signal Pharmaceuticals, Inc. His experience in these organizations has allowed him to refine his skills and contribute to groundbreaking research and development in drug formulations.

Collaborations

Throughout his career, Parikh has collaborated with esteemed colleagues such as Scott Burnside and Sreenivas S Bhat. These partnerships have fostered an environment of innovation and have led to the successful development of various pharmaceutical solutions.

Conclusion

Darshan Parikh's work exemplifies the spirit of innovation in the pharmaceutical industry. His numerous patents and collaborations highlight his commitment to advancing medical science and improving patient outcomes.

This text is generated by artificial intelligence and may not be accurate.